ISB News

Tuberculosis: ‘The Forgotten Plague’

PBS: American Experience Film
“The Forgotten Plague”

BY ISBUSA

The measles outbreak and subsequent fueling of the anti-vaccination debate have monopolized headlines recently. But there’s a “plague” that causes an estimated 1.3 million deaths per year that researchers, including those at Institute for Systems Biology, are dedicated to tackling: tuberculosis. On Tuesday, Feb. 10, PBS will feature an “American Experience” film “The Forgotten Plague” on the history of tuberculosis and how difficult it has been to eradicate this disease. Check local listings for times.

LEARN MORE ABOUT ISB’S TUBERCULOSIS RESEARCH:

Pushing the Molecular Switches of Tuberculosis Into Overdrive to Map Interactions

Uncovering the Genetic Adaptability of Tuberculosis

ISB Researchers Identify New Protein Modification Critical to Growth of Tuberculosis Pathogen

ISB Researchers Collaborate on $16.6 Million Tuberculosis Grant

TB IN KING COUNTY, WA:

KCTS 9 shared a report on TB stats for King County to dovetail with the Frontline episode “TB Silent Killer.” Learn more..


 

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.